You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

AEROLATE JR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Aerolate Jr patents expire, and when can generic versions of Aerolate Jr launch?

Aerolate Jr is a drug marketed by Fleming Pharms and is included in one NDA.

The generic ingredient in AEROLATE JR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aerolate Jr

A generic version of AEROLATE JR was approved as theophylline by RHODES PHARMS on September 1st, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AEROLATE JR?
  • What are the global sales for AEROLATE JR?
  • What is Average Wholesale Price for AEROLATE JR?
Summary for AEROLATE JR
Drug patent expirations by year for AEROLATE JR

US Patents and Regulatory Information for AEROLATE JR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fleming Pharms AEROLATE JR theophylline CAPSULE, EXTENDED RELEASE;ORAL 085075-002 Nov 24, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.